SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950116-01-500498
Filing Date
2001-07-17
Accepted
2001-07-17 00:00:00
Documents
10
Period of Report
2001-07-06
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8-k.txt 8-K 14242
2 SPA1.TXT spa1.txt EX-1 53669
3 RRA1.TXT rra1.txt EX-2 54687
4 W1.TXT w1.txt EX-3 35325
5 spa2.txt EX-4 55086
6 RRA2.TXT rra2.txt EX-5 54643
7 W2.TXT w2.txt EX-6 37325
8 SPA3.TXT spa3.txt EX-7 53926
9 RRA3.TXT rra3.txt EX-8 54861
10 W3.TXT w3.txt EX-9 38004
  Complete submission text file 0000950116-01-500498.txt   454127
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 1683345
SIC: 2834 Pharmaceutical Preparations